Shire

FDA approves Vyvanse generics
ADHD News & Research

Vyvanse Generics Roll Out — And Disappoint

As the U.S. patent for Vyvanse expired August 2023, the FDA cleared 14  manufacturers to produce Vyvanse generics.  It might take several months for a significant number of consumers to access these Vyvanse generics. At

Read More »
Mydayis from Takeda finally gets FDA approval. Triple-bead action
ADHD News & Research

Mydayis: Longer-Lasting Adderall

In case you missed it, there is a longer-lasting version of Adderall, called Mydayis. Many people report frustration with the current Adderall shortage.  I suggest that a trial of Mydayis would be worth a shot—and

Read More »

MORE FROM GINA

Stay in Touch!
Ride the ADHD Roller Coaster
Without Getting Whiplash!
Receive Gina Pera's award-winning blog posts and news of webinars and workshops.
P.S. Your time and privacy—Respected.
No e-mail bombardment—Promised.
No Thanks!
close-link